Acute reactions and dosimetry associated with old and new adjuvant radiation in carcinoma breast
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2024/07/071736
- Lead Sponsor
- Dr.Harikrishna Suresh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients who are above the age of 18 years diagnosed with early stage or locally advanced carcinoma breast, has undergone mastectomy or breast conservative surgery who will be required to undergo adjuvant radiotherapy.
Exclusion Criteria
PATIENTS WITH METASTATIC DISEASE
PATIENTS WITH RELAPSE
MENTALLY CHALLENGED PATIENTS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the acute reactions IN both conventional and hypo fractionated regimens. <br/ ><br> <br/ ><br>Timepoint: BEFORE THE STARTING OF THE TREATMENT 0 WEEK <br/ ><br>DURING THE TREATMENT 4 TH WEEK <br/ ><br>POST TREATMENT 2 MONTH 6 MONTHS
- Secondary Outcome Measures
Name Time Method To assess the quality of lifeTimepoint: At the end of the treatment <br/ ><br>At 3 MONTHS AND 6 MONTHS AFTER COMPLETION OF THE TREATMENT